Abstract
The rising burden of cardiovascular disease (CVD) has made the achievement of optimal lipoprotein levels a major public health priority. As nearly a fifth of global mortality is associated with dietary factors, and recommendations have been mired in controversy, a fresh look on the available data is attempted. Well established concepts regarding nutrition and cardiometabolic health, role of macronutrients, calories, and controversial foods are discussed followed by recommendations in the Indian context. A healthy dietary pattern rather than individual foods or nutrients is emphasized, and this is generally plant based with optional consumption of dairy, eggs, and meats within the suggested limits. Suggestions/recommendations are given for consumption of individual foods, remembering that choosing appropriate replacement foods is as important as restricting unhealthy foods.
Keywords: Diet, Cardio-metabolic health, Dyslipidemia, Calories, Macronutrients
1. Introduction
Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD),1,2 which accounts for nearly a third of total mortality, making the achievement of optimal lipoprotein levels a priority for community health.3 India experienced a near doubling of CVD mortality between 1990 and 2016 with a recent analysis ascribing 56.4 % of CVD risk to dietary factors, commensurate with the approximately 11 million deaths that are attributable to diet associated risk factors globally.3,4
Studies on food items are subject to bias and uncertainty as these data are derived from small experimental studies and large observational studies, usually based on food frequency questionnaires (FFQ) filled by a small subset of the population being studied, typically at one point in time, and for a limited period.5 Furthermore, dietary patterns change over time, both as the population grows older and as new concepts become public, making diets difficult to control in the long-term in a free-living population. Inconsistent data and conflicting, often unsupported dietary advice over the last half century have led to confusion regarding a healthy diet.
Some concepts that are well established are summarized here:
-
1.
Diet and exercise strongly influence cardio-metabolic risk factors. Easily assessed parameters like body weight, body fat (especially visceral fat), blood sugar, lipid levels, blood pressure, hepatic and renal function, lean muscle and bone mass, and more complex interactions like inflammation, oxidative stress, endothelial health, and the gut microbiome are regulated and modified by our food and physical activity, probably through hormonal and other influences.6
-
2.
Total macronutrients (carbohydrates, fats and proteins) are neutral for obesity, diabetes and CVD, implying that individual food choices rather than proportion of nutrients influence health.6,7 Large studies failed to show any major benefits with low fat or low saturated fat diets.8, 9, 10, 11, 12, 13, 14 Conversely, better outcomes were reported with higher fat diets15,16 providing more than 40 % of daily calories from fats without altering cholesterol levels, suggesting that the previous focus on total calories, macronutrients, total and saturated fats needs to be modified to look at dietary patterns, both for optimal lipoprotein levels and reducing CVD risk.6,7,10,12,13 Of the evaluated diets, the Mediterranean6,10,15,16 and Dietary Approaches to Stop Hypertension (DASH) diets have the maximum supportive evidence.6,10,17,18
-
3.
There is a strong link between weight gain, glucose intolerance and cardiometabolic disease; likewise, ≈15 kg weight loss by lifestyle changes or bariatric surgery can result in remission of type 2 diabetes (T2D) in ∼80 % subjects.19,20 Maintaining ideal body weight is thus integral to maintaining insulin sensitivity, achieving optimal lipoprotein levels, and minimizing ASCVD risk.6,20
-
4.
Mounting evidence of a body weight set point in the hypothalamus suggests that the belief that obesity and weight gain are only due to energy imbalance (“calories in, calories out,” hypothesis) is an oversimplification of a complex metabolic process.6,21,22 Calorie restriction or exercise result in initial weight loss that is notoriously difficult to maintain. Weight maintenance is best achieved using healthy dietary patterns combined with regular exercise, without necessarily counting calories or relative proportions of macronutrients.6,21, 22, 23, 24, 25, 26 Healthy foods result in greater satiety and/or have higher metabolic expenditure even if they are calorie-dense, while unhealthy foods are usually associated with quick bursts of energy followed by troughs, leading to craving for foods/snacks (related to brain reward mechanisms) predisposing to insulin resistance, obesity and potential adverse effects upon the gut microbiome.6,10,22,24,27, 28, 29, 30
-
5.
In obese and/or insulin resistant (IR) individuals, the liver responds to excess calories (particularly refined carbohydrates) by increased secretion of triglyceride (TG)-rich very low density lipoprotein (VLDL) particles.31 Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesterol and TGs between high density lipoproteins (HDL), LDL and VLDL, generating smaller cholesterol poor HDL and LDL particles.32 The smaller HDL particles are easily excreted by the kidneys, lowering HDL-C, whereas smaller LDL particles penetrate endothelium more easily and are vulnerable to oxidation, making them more atherogenic. The increased VLDL particles are more atherogenic (cholesterol-rich) and increase the Apo B particle number (Apolipoprotein B100 is the primary protein constituent of lipoproteins LDL and VLDL-their particle number serves as a better marker of atherogenicity than simply LDL-C levels), while calculated LDL cholesterol (LDL-C) remains around the normal range.1,31 Thus in individuals with metabolic syndrome, type 2 diabetes and hypertriglyceridemia, Apo B correlates better with ASCVD risk due to discordance between LDL particle number and calculated levels, the driver of atherogenic dyslipidaemia being excess calories, especially as refined carbohydrates.1,12,31 This is increasingly important as 1/3–1/2 of the adult population in many countries has diabetes or prediabetes,33 and VLDL/remnant cholesterol contributes significantly to the burden of coronary artery disease.34
2. Fats
Whereas polyunsaturated fatty acids (PUFA) appear to be the healthiest nutrient metabolically, the Food and Nutrition Board Institute of Medicine sets No Tolerable Upper Intake Level for total fat.35 The intervention arms in the major trial supporting Mediterranean diet consumed 41 % calories from fats, which contributed to the removal of cut-offs for total fats in guidelines.36 Only trans-fats (bakery items, fried foods, hydrogenated vegetable oils, most over-the-counter snacks) are unequivocally linked to increased ASCVD and hence are proscribed completely.6,10,11
3. Total fats, saturated fats, cholesterol and cooking oils
Experimental studies carrying out direct substitution of nutrients,37 as well as large cohort studies that model the effects of nutrient substitution uniformly conclude that iso-calorically replacing saturated fatty acids (SFA) or carbohydrates by PUFA is beneficial and by monounsaturated fatty acids (MUFA), neutral for the lipoproteins, whereas substituting SFA with total carbohydrates worsens TGs and HDL-C and lowers LDL-C, a change that is better or worse depending upon the quality of carbohydrate.6,10,12,37 However, foods are different from drugs, i.e. extrapolating the benefits of lower LDL-C with food does not guarantee similar CVD reduction as achieved with statins. Examples include failed trials with niacin,38 CETP inhibitors39 and estrogen supplements9; furthermore, benefits observed with foods have never been replicated with nutrients given as drugs.6,7
Saturated fats have been considered a major risk factor for CVD6,10,11,40, 41, 42 owing to increased LDL-C levels, a change which may be offset by their other effects: increased HDL-C (maintaining the TC/HDL-C ratio) while substantially reducing triglycerides,37 no major impact on Apo B,12 and lower lipoprotein(a) levels.43 Conclusive evidence of CVD risk is unproven: all 10 meta-analyses of observational studies evaluating the association of SFA with CVD were negative (only 2 reported benefits on replacing SFA with PUFA), as were 7 of 10 meta-analyses of RCTs; the 3 positive meta-analyses reported lower combined CVD endpoints, and not mortality.44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54 The positive analyses included the “4 core trials” that form the basis of AHA guidelines, which have been criticized for design flaws (poorly controlled), being outdated (over 50 years old) and comparing consumption of trans- and saturated fats (rather than SFA alone) vs PUFA.40,44 Finally, all 8 meta-analyses evaluating the association of foods rich in saturated fats with CVD were negative44; a large trial reported lack of change in lipoproteins with higher SFA consumption in the setting of a natural diet with low refined carbohydrates.55 There is even a study demonstrating least progression of coronary atherosclerosis in women who consumed more saturated fats than those consuming higher carbohydrates or PUFA.56
PREDIMED reported 30 % reduction in CVD endpoints with Mediterranean diet, but had similar 9 % SFA intake in all arms, the difference being extra unsaturated fat intake in the two active arms in the context of a higher than usual fat intake (approximately 41 % of daily calories).15,36 Thus, some guidelines recommend that replacing refined carbohydrates with saturated fat could be metabolically healthy10,46,57; an alternative suggestion is to limit total carbohydrate and SFA rather than SFA alone.10
One reason for the continuing controversy could be the reported association of plasma SFA levels with metabolic syndrome, diabetes and CVD, but it is noteworthy that these levels are proportional to the total carbohydrate, and not fat intake, as higher saturated fats with low carbohydrate consumption results in lower circulating SFA levels (due to greater fat oxidation and suppression of hepatic lipogenesis).6,10,45 Furthermore, SFA are heterogenous, found in both healthy and unhealthy foods (for instance, cheese, curd, butter, chicken, seafood, meats, fried foods, oils and nuts), making judging a fat by its fatty acid content imperfect.6,10,45,58
Randomized controlled trials of PUFA substitution or supplementation are inconsistent: Some substitution studies report reduction of CVD endpoints,10,35,59 but the results of the two largest studies60,61 reported reduction in cholesterol levels but a possible increase in mortality; hence, the results of meta-analyses depend upon the studies included or excluded. Reassuring data in favor of linoleic acid (n-6) comes from a recent large meta-analysis of prospective cohort studies that reported significant reductions in CVD, cancer and mortality.62
The same is true of supplementation: whereas PREDIMED, which added fats as foods (nuts or extra-virgin olive oil [EVOO]) is positive,15 all trials of nutrient supplementation are negative, except REDUCE-IT,63 which reported significant 20 % mortality reduction with supplemental n-3 fatty acid icosapent ethyl (purified ethyl ester of eicosapentaenoic acid, EPA) in subjects with elevated TGs on statins. As STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH)64 studying EPA + DHA combination and VITAL65 testing vitamin D3 and lower dose EPA + DHA combination reported neutral results, we are without clear answers.
In sum, healthy fat containing foods (e.g., nuts, EVOO, some dairy fats) may be beneficial in comparison to refined, processed carbohydrates, unsaturated fats are a healthy addition to diet replacing refined carbohydrates and unhealthy saturated fats, n-3 PUFA supplements (especially EPA) may be useful in reducing CVD events in moderate-to high-risk individuals with high triglycerides, and n-6 PUFA may be useful, provided saturated fat is not strongly restricted.6,10,15,62,63 Restricting SFA to under 6 % of total daily calories is unsupported; however, a dietary pattern based on healthy fats is recommended.6,7,10,40
Oils are classified on their fatty acid content (which make >95 % of the oil), but the remaining non-glyceride components are also important, and include sterols, alcohols, tocols (tocophenols and trocotrienols), phenolic compounds, complex lipids and unique components like ubiquinones, lignans and flavonoids.66 Again, data is conflicting: several meta-analyses44,45,49,51,53 have reported neutral effects of SFA on CVD outcomes, especially butter and ghee (clarified butter) and even possible benefit of dairy fats in reducing diabetes.67, 68, 69 The epidemiological evidence for MUFA is mixed, with mostly neutral, rare negative and some positive results.6,10,15,36 The choice is even tougher in India, where the average fat consumption is much lower than in the West (14 % vs 32 % of total calories), the predominant oils are rich in n-6 PUFA (sunflower, safflower, rice bran, proprietary blends), saturated fats are restricted, especially in cities; yet we have growing numbers of individuals with obesity, metabolic syndrome and CVD.4,70 This has been attributed to highly refined vegetable oils rich in n-6 PUFA like sunflower oil, which is at odds with guideline recommendations.70,71
Extra-virgin olive oil (EVOO) high in oleic acid (MUFA) and containing phenolic compounds appears to be the healthiest10,15,71; benefits are also reported with canola oil in elevating HDL-C and reducing TGs and BP, as well as preventing recurrent CVD events.16,72 The recent practice of blending oils to obtain a healthy fatty acid composition (an optimal mixture of MUFA and PUFA, with other healthy non-glyceride components) may thus be reasonable but is yet to be studied systematically.10,72 Coconut oil has been discarded without a fair trial in view of high SFA content: despite having >80 % SFA, lipoprotein changes on a diet enriched with coconut oil may be similar to olive oil.73 This is consistent with decreased TC:HDL-C ratio when lauric acid replaces carbohydrates emphasizing that lipoproteins depend upon foods consumed and cooking methods in addition to fatty acid content.6,10,45,73 Considering that these have been staple in many parts of India, coconut and mustard oil (which has similarities with canola oil) deserve further evaluation. Finally, few studies have examined the effects of high temperature cooking on oils: Biochemical properties suggest that SFA are the most heat stable, followed by MUFA, whereas PUFA are unstable and more likely to get denatured with frying.45 This could be a reason for the largely neutral results of using ghee,67, 68, 69 and the better outcomes even in overweight individuals using EVOO15,74; controlled trials studying relative effects of vegetable oils, ghee, mustard and coconut oils are urgently needed.
As of now, the evidence supports the consumption of EVOO and canola oil, followed by healthy proprietary blends that aim for a healthy mix of MUFA, n-3 PUFA and n-6 PUFA (Dietary Guidelines for Indians by National Institute of Nutrition (NIN) recommends a blend of groundnut or sesame or rice bran oil with mustard or canola or soyabean oil). PREDIMED recommended over 4 tablespoons (50 g) of EVOO daily, whereas NIN recommends 20–50 g of visible fat per day depending on activity levels.75 Fried foods should be avoided; occasional (≤ once a week) frying may be done in oils with a high smoking point (ghee or clarified butter or mustard oil).
There is inconsistent evidence for recommending specific n-3/n-6 fatty acid ratios of refined oils, as discussed above. As there is data suggesting pro-inflammatory effects of n-6 fatty acids (through arachidonic acid pathway) which reduce the metabolism of dietary alpha linolenic acid to EPA and DHA,74 besides purported effects on endocannabinoid system (associated with obesity, inflammation, cancers),76,77 but also safety data from a meta-analysis,62 it would be prudent to suggest a ratio of <1:5, and definitely <1:10 (commercially available foods typically have ratios over 1:20–60).6,10
4. Proteins
Guidelines advising restriction of meats (and fats) and compensation with carbohydrates have resulted in reduction in the average daily intake of protein to <15 % of total calories, whereas a healthier proportion may be closer to 15–25 %.6 Total proteins appear to have little effect on important risk factors like blood sugar, blood pressure, serum lipid levels or obesity and on the basis of limited studies, appear to be neutral for CVD risk.6,78 There are isolated reports of some protection from hemorrhagic strokes seen with animal protein intake; a possible protective effect on vascular fragility has been proposed.6 Notably, like total fats or carbohydrates, proteins come from a variety of sources, both healthy (nuts, seeds, fish, cheese, curd, etc.) and unhealthy (red meats—processed and unprocessed), suggesting that it is individual foods and their mode of cooking rather than macronutrients per se that are critical for overall health.6,7
5. Carbohydrates
Carbohydrates account for 50 % or more of the daily calorie intake in most populations. It is difficult to recommend unrestricted consumption of carbohydrates or very low carbohydrate diets (Atkins’ diet or Keto diets - these are still shrouded in controversy).6,7,26 Whereas carbohydrates are neutral for cardiometabolic health overall, refined and processed carbohydrates are unhealthy and are associated with obesity, diabetes, lipid abnormalities, hypertension and CVD,6,10,27, 28, 29, 30,79 the effects on inducing/aggravating insulin resistance and weight gain being worse in women, older and sedentary individuals.6 The body metabolizes potatoes and refined flour similarly to sugar (as these apparently complex carbohydrates are only glucose molecules stringed together), hence, what is important is their preparation—the fiber content, level of processing and whole grain content, all of which determine the glycemic response to a food (determined by the glycemic index (GI) and the glycemic loads of foods).6,7,24,27, 28, 29, 30
6. Wheat and wheat products
The Green Revolution transformed agriculture by hybridization of the wheat crop: This grew faster, was winter hardy and gave a larger harvest; however, the protein gluten was different, and Amylopectin A provided high glycemic index (white bread has GI similar to sugar).80 Current wheat (Triticum aestivum) has 70 % carbohydrate, 10–15 % each of indigestible fiber and proteins and a small amount of fat.6,80 The glycemic response to grains is low if eaten whole or with minimal processing (quinoa, brown rice or steel-cut oats—the bran protects the starchy endosperm portion from easy digestion), is higher if the grain is milled (bran is present, but the starchy endosperm is more exposed leading to early digestion, e.g., chapati made from traditional flour, whole-grain breads, some cereals) and is highest if the bran and germ are totally removed by processing (leaving the easily digestible starchy portion e.g., white bread, white rice, most cereals like corn flakes and highly refined flour), again reinforcing foods over macronutrient composition.6,7
As wheat products are ubiquitous, it is reasonable to continue moderate intakes (up to 3 servings a day) including chapatis, breads, or cereal.
7. Eggs
It is now accepted that dietary cholesterol has neutral associations with CVD, and in usually consumed amounts, has minor effects on serum cholesterol.81,82
Eggs, a major source of cholesterol, are also rich in complete proteins and fat-soluble vitamins.81,82 Large observational studies suggest no association of eggs with CVD, rather a possible association with diabetes in people consuming >14 eggs per week, which is controversial as all possible results (negative, neutral and positive associations with diabetes) are reported.83, 84, 85, 86 Three large studies on egg consumption published recently reported contrasting results. An American study84 of over 29,000 adults showed a higher risk of CVD and all-cause mortality, whereas a Chinese study85 in half a million adults suggested lower risk of CVD with ≤1 egg/day. PURE found no association of egg intake (≥7/week vs < 1 egg/week) with lipoprotein levels, major CVD events or mortality in 1,77,000 subjects.86
In summary, eggs would appear to be healthy if replacing foods like red meats, fried foods, and refined carbohydrates, but may be less healthy than non-starchy vegetables, fruits, and fish, making 1 whole egg a day acceptable in healthy individuals (two in those who are primarily vegetarians).6,82
8. Milk and milk products
Conventionally lumped together as a single entity, usual dietary recommendations are to use low-fat dairy to reduce saturated fats, even though low-fat milk in children (but not adults) is associated with more weight gain.6 Like all foods, milk products have heterogenous effects on the metabolism; for instance, curd and cheese, but not milk, are associated with a reduced risk of diabetes and weight loss if replacing carbohydrates; this suggests a beneficial effect of fermentation on milk, possibly because of the synthesis of vitamin K2 by bacterial cultures or the presence of probiotics in curd.6,10,67, 68, 69 Several meta-analyses report protective effects of dairy fat and butter on diabetes risk, due to the zero GI, and no association with CHD, stroke or total mortality.67, 68, 69 The available evidence points to the benefits of regular consumption of curd and probably cheese as well6,10,67, 68, 69; three recent analyses report little difference between low-fat and full-fat varieties in 3 US and 1 Italian cohort, further strengthening the case for recommending dairy products to healthy children and adults.87
Healthy children and adults may consume low-fat or full-fat milk as per personal choice, whereas dairy fat and butter appear to be metabolically safe with possible protective effects on diabetes risk. The recommendation is to advise consumption of curd and cheese over milk for weight loss and reducing the risk of diabetes.
9. Coffee and tea
Coffee is associated with reduction in the risk of diabetes in a dose-dependent manner, whether with caffeine or decaffeinated. The effect on CHD and stroke is more complex: observational studies appear to suggest a J-shaped relation, i.e., protective till 3–4 cups per day and possibility of harm above 5–6 cups per day; randomized trials have been small and inconsistent.88 A large study recently reported lower CVD and mortality with coffee consumption with maximum protection at 2–3 cups a day.89 Tea is associated with similar benefit in reducing the incidence of CVD and diabetes, especially with >3–4 cups per day. In sum, the recommendation is to permit the consumption of tea and coffee, with some evidence of a benefit of black and green tea in reducing CVD risk.90
10. Sodium
Sodium increases blood pressure in a dose-dependent fashion, especially with intakes >5 g/day and in individuals with hypertension.91,92 One meta-analysis of prospective cohort studies reported an increased risk of stroke and stroke mortality at high intake,92 however, there is limited evidence of a linear association with cardiac or total mortality in RCTs or cohort studies.91,93, 94, 95, 96, 97, 98, 99, 100 Rather, several meta-analyses of prospective observational studies report a J/U-shaped mortality curve, suggesting a troubling increase in all-cause mortality with low-sodium diets both in hypertensive as well as normotensive individuals.93,96 The average global consumption of sodium is estimated at 3.95 g/day (approximately 10 g of salt)101 and exceeds most dietary guidelines that recommend <2–2.3 g/day, whereas the number of people consuming this level is <10 % in US and even lesser elsewhere (of over one lakh individuals in PURE, sodium excretion was <3 g in 11 % and <2.3 g in just 0.2 %).95, 96, 97,100 A recent study found no benefits in restricting sodium <2.3 g/day in heart failure, making even this indication suspect.102
Guidelines are based on one 30-day diet trial103 showing BP lowering and short-term safety of 1.5 g sodium, and two longer trials of intensive dietary counselling.104,105 The bigger of these104 managed to achieve an intake of 3.2 g/day in the intervention arm (<10 % achieving <2.3 g) compared to 4 g in the control arm. While some investigators claim potential 32 % reduction of CVD risk with restriction of daily sodium intake to 2.3 g,91 this remains controversial as this target has not been achieved anywhere outside a trial. Other problems include difficulty in reliable measurement of sodium intake, and in achieving or quantifying such severe restriction (maximum sodium decrease in populations has been 0.5 g/day with intensive counselling and food industry involvement).95,98
Two recent reports rekindled interest in salt restriction: an observational study reported an association of added salt on table with mortality106 and a trial demonstrated reduction in CVD and mortality in high-risk hypertensives using salt substitutes.107 Of note, the former analysis reconfirmed that the harms of added salt were neutralized in those consuming potassium-rich foods like fruits, vegetables and nuts.95,106 This is very relevant in India with estimated intake of 3.72–5 g/day101,108 where >80 % of the salt is added (in comparison to 5–20 % in high income countries) at the table.108
As there is clear benefit only for hypertensive individuals with high intakes, and possible risks for low intakes in all, a practical approach would be to advise restriction of added salt by educating populations and industry in order to achieve the WHO 2025 goal of reducing population salt intake by 30 %.95,98,100,106,107
11. Miscellaneous
Compounds like flavonols (onions, broccoli, many fruits, especially berries, tea), flavones (parsley), isoflavones (soy), catechins (cocoa, grapes, red wine, tea), etc. have documented cardiometabolic effects, though their variability precludes definite guidelines; several food items deemed healthy (EVOO, nuts and berries) are rich in these compounds.6,10,15,71
Though observational studies suggested a reduced risk of CVD with vitamins, RCTs involving folate, vitamin B group, beta-carotene, and vitamins C and E have been neutral.6 Reasons could be that the duration of treatment was not long enough, or that these are more effective for primary than secondary prevention. It is also possible that the benefits seen with vegetables, fruits and nuts may be secondary to factors (dietary or non-dietary) other than vitamins, hence their benefit is not replicated by synthetic vitamins. Vitamin D has invited extensive investigation recently: there is currently no evidence for its role in preventing CVD.6 Higher intake of potassium may be useful, e.g., fruits, vegetables and nuts like the Mediterranean diet or the modified DASH diet (with higher fat) lower the risk of CVD, and are very beneficial, if taken regularly.6,10,15,17,18,95,96,98,100
12. Dietary approach to lipid management
As LDL-C is widely recognized as causative for ASCVD, the focus of clinical management is on lowering LDL-C using statins and other agents.1,2 However, from a community health perspective, it's important to recognize two different types of lipid disorders: isolated high LDL-C and metabolic/atherogenic dyslipidemia, as these differ both in etiology as well as dietary management. Isolated LDL-C elevation is less common and responds best to restriction of trans-as well as saturated fats, whereas the more common metabolic dyslipidemia (high triglycerides, low HDL-C) is managed better by restriction of total calories, especially sugars and refined carbohydrates.6,31,36,37,40,109
In view of lack of robust evidence linking specific nutrient consumption with optimal health and the difficulties involved in calculating such figures, a practical approach is presented. Also refer to Table 1, Table 2, Table 3 for additional information.
Table 1.
Healthy or health neutral foods with evidence base.
| Broad consensus | General consensus, few doubts | Controversy as to evidence and prevailing guidelines |
|---|---|---|
| Fresh vegetables, dietary fibre | n-6 PUFA | Low fat milk |
| Curd/yogurt | Plant derived MUFA | Cheese, dairy fat |
| Fresh fruits | Certain oils (EVOO, canola) | Certain oils (sunflower, safflower) |
| Nuts and seeds | White meats | Eggs |
| Whole grains | Phenolics, flavones | Probiotics |
| Fish and fish oil | Tea/coffee | Vitamin D |
| Legumes n-3 PUFA |
EVOO: Extra-virgin olive oil, PUFA: Polyunsaturated fatty acids, MUFA: Monounsaturated fatty acids.
Table 2.
Foods considered unhealthy.
| Broad consensus | General consensus, few doubts | Controversy as to evidence and prevailing guidelines |
|---|---|---|
| Processed meats | White potatoes | Saturated fats, butter Coconut oil |
| Partially hydrogenated vegetable oils (TFA) | Unrestricted unprocessed red meats | Dietary cholesterol |
| Refined grains and starch | Whole fat milk | |
| Sugars and SSBs | Non-calorie sweeteners | |
| Excess sodium | Moderate amounts of unprocessed meats | |
| Excess alcohol | ||
| Sweets and desserts |
TFA: Trans fatty acids, SSBs: Sugar sweetened beverages.
Table 3.
General dietary recommendations.
| Foods | Recommended amount (servings) | Size of 1 serving |
|---|---|---|
| Fresh vegetables, legumes | 3–5 per day | 1 cup raw veg, 1/2 cup cooked or cut veg, veg soup |
| Fresh fruits | 2–3 per day | 1medium size fruit, 1/2 cup fresh or unsweetened canned fruits, one piece about the size of your palm |
| Nuts and seeds | 1 per day | 1 ounce or a small handful of nuts |
| Whole grains | 2–3 per day | 1 medium chapati (multigrain/flour with bran, 1 slice whole grain bread, 1 cup high fibre cereal, 1/2 cup cooked brown rice |
| Dairy | 2–3 per day | 1 cup milk/curd (preferred), 1 ounce (∼28 g) cheese |
| Fish/seafoods | 2–3 per week | 100 g |
| Vegetable oils | 2–5 per day | 1 tsp oil, prefer unrefined virgin/extra virgin oils |
| Processed meats | Maximum 1 per week | 50 g |
| Unprocessed meats | 1–3 per week | 100 g |
| Refined grains | <1–2 per day | 1 medium chapati (refined flour), 1 slice bread, 1/2 cup rice or cereal, 1 small sweet or dessert |
| Hydrogenated oils | Avoid as much as possible | Foods made with partially hydrogenated oils, fried foods (especially re-frying in same oil) |
| Sugar sweetened beverages | Avoid as much as possible | 300 ml |
| Sodium | <2.3 g recommended, 2–5 g may be acceptable per day | Not relevant |
| Eggs | 1–2 whole eggs per day | 1 egg |
| Alcohol | 1–2 small drinks males 1 small drink females a few times a week |
10 g of ethyl alcohol |
| Tea | 3–5 cups per day | 2 g loose tea in 200 ml or 8 oz boiled water |
| Coffee | 1–3 cups per day | 1 tablespoon full of coffee in 6 oz (∼170 ml) cup |
12.1. Category 1: foods for which there is consensus that they are unhealthy
These include trans fats, processed meats, some oils (hydrogenated vegetable oils), refined carbohydrates, starches, sugars, sugar sweetened beverages (SSB) and excess salt. These should be avoided, except for fresh unprocessed meats, which may be consumed occasionally (discussed below).
Industrially produced trans-fatty acids (TFA) in hydrogenated oils (developed to increase the shelf life of oils without becoming rancid, and making them more suitable for frying, baking and packaging foods) raise LDL-C, TGs and Apo B, while lowering HDL-C and Apo A; other effects include insulin resistance, visceral obesity, inflammation, damage to vascular endothelium and possibly increased cardiac arrhythmias.6,10,11 As frying at high temperatures generates further TFA, frying in the same oil repeatedly, a common practice in sweet shops (and most Indian homes) should be avoided. Sugars should be restricted, being worse than “empty calories”; SSBs are highly addictive, being consistently linked with diabetes, heart disease and cancers.41,42,110, 111, 112, 113, 114
12.2. Category 2: foods about which there is consensus that they are useful or neutral for CVD
Compelling evidence exists for the benefits of eating non-starchy vegetables, especially green, leafy vegetables,3,4,6,7,115 a moderate consumption of fruits,3,4,6,7,115 nuts,6,10,116 seeds, fatty fish and fish oils.6,7,10,11 Other healthy foods include whole grains, legumes,116 some extra-virgin (unrefined) oils and non-fat components in vegetable oils like phenolics, whereas some dairy items (curd and cheese), white meats, tea and coffee are neutral or possibly healthy. These food items consistently improve metabolic and biochemical parameters, are neutral or beneficial for weight maintenance and reduce CVD risk; low intake of whole grains and fruits were among the three leading dietary risk factors for death globally.3 These foods can be consumed liberally, especially if they replace foods in category 1.
12.3. Category 3: Controversial foods
Saturated fats, wheat products, meats, other dairy items (low-fat or full-fat milk, butter, ghee), eggs, vitamin D, specific oils and fatty acids, and probiotics have conflicting data; there is too little evidence to draw conclusions upon some other popular recommendations like organic foods, grass-fed or grain-fed, modified or non-genetically modified foods. Meats are controversial as there are opposing recommendations (fresh vs processed, white vs red meats); presently, it is reasonable to recommend intake of fresh unprocessed meats (< once daily, up to 1–3 times a week) as the evidence implicating them in causing diabetes or CVD is weak.117, 118, 119, 120, 121 There is little data to support the recommendation that meats should be chosen based on their fat content6,10; a recent nutritional guideline has rather given a weak recommendation to continue current levels of meat intake due to the very poor evidence linking meats to CVD, diabetes or cancers.58
Several questions remain unanswered. These include, but are not limited to:
-
1.
Confirmation of the benefits of consuming PUFA instead of other fats and carbohydrates.
-
2.
The ideal cooking oil and the optimal n-3/n-6 ratio.
-
3.
The putative health effects of low carbohydrate diets (<26 % daily calories)
13. Conclusion
Carbohydrates, fats and proteins are not harmful in themselves: Food items and their preparations are healthy or unhealthy; this knowledge directs us to choose healthy foods rather than macronutrients. The available data supports the consumption of a plant-based omnivorous diet, rich in natural foods with low consumption of salt and meats, and minimal intake of sugars and processed foods. Fats are not to be treated as poison, and nor are carbohydrates; rather a balanced diet contains all of them. Perhaps a reduction of carbohydrates by 10–15 % (especially sugars, SSBs and refined carbohydrates) and adding some healthy fats and proteins is the best option.6,10 Furthermore, incomplete data from genetically distinct populations consuming different foods using dissimilar cooking methods cannot be applied blindly in our country, and we need more local studies to clearly define the best foods and cooking practices in our context.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
- 1.Ference B.A., Ginsberg H.N., Graham I., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472J. doi: 10.1093/eurheartj/ehx144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Borén J., Chapman M.J., Krauss R.M., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: 2. pathophysiological, genetic and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41(24):2313–2330. doi: 10.1093/eurheartj/ehz962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. GBD 2017 Diet Collaborators. 10.1016/S0140-6736(19)30041-8. [DOI] [PMC free article] [PubMed]
- 4.Satija A., Yu E., Willett W.C., Hu F.B. Understanding nutritional epidemiology and its role in policy. Adv Nutr. 2015;6:5–18. doi: 10.3945/an.114.007492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.India State Level Disease Burden Initiative CVD Collaborators The changing pattern of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016. Lancet Public Health. 2018;3:e478–e489. doi: 10.1016/S2468-2667(18)30138-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mozaffarian D. Dietary and policy priorities for CVD, diabetes and obesity: a comprehensive review. Circulation. 2016;133:187–225. doi: 10.1161/CIRCULATIONAHA.115.018585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mozaffarian D., Ludwig D.S. Dietary guidelines in the 21st century-a time for food. JAMA. 2010;304:681–682. doi: 10.1001/jama.2010.1116. [DOI] [PubMed] [Google Scholar]
- 8.Hession M., Rolland C., Kulkarni U., et al. Systematic review of randomized controlled trials of low-carbohydrate VS low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev. 2009;10:36–50. doi: 10.1111/j.1467-789X.2008.00518.x. [DOI] [PubMed] [Google Scholar]
- 9.Howard Barbara V., Van Horn L., Hsia J, et al. For the women’s health initiative randomized controlled dietary modification trial: Low- fat dietary pattern and risk of cardiovascular disease. JAMA. 2006;295:655–666. doi: 10.1001/jama.295.6.655. [DOI] [PubMed] [Google Scholar]
- 10.Liu A.G., Ford N.A., Hu F.B., et al. A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion. Nutr J. 2017;16(1):53. doi: 10.1186/s12937-017-0271-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.de Souza R.J., Mente A., Maroleanu A., et al. Intake of saturated and trans unsaturated fatty acids and risk of all-cause mortality, Cardiovascular disease, and type 2 diabetes systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978. doi: 10.1136/bmj.h3978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mente A., Dehghan M., Rangrajan A., et al. On behalf of the PURE study investigators. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE srudy. Lancet Diabetes Endocrinol. 2017;5:774–787. doi: 10.1016/S2213-8587(17)30283-8. [DOI] [PubMed] [Google Scholar]
- 13.Dehghan M., Mente A., Zhang X., et al. On behalf of the PURE study investigators. Association of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390:2050–2062. doi: 10.1016/S0140-6736(17)32252-3. [DOI] [PubMed] [Google Scholar]
- 14.Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. The look AHEAD research group. N Engl J Med. 2013;369:145–154. doi: 10.1056/NEJMoa1212914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Estruch R., Ros E., Sales- Salvado J., et al. For the PREDIMED study investigators. Primary prevention of cardiovascular disease with a mediterranean diet. N Engl J Med. 2013;368:1279–1290. doi: 10.1056/NEJMoa1200303. [DOI] [PubMed] [Google Scholar]
- 16.de Lorgeril M., Salen P., Martin J.L., et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779–785. doi: 10.1161/01.cir.99.6.779. [DOI] [PubMed] [Google Scholar]
- 17.Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med. 1997;336(16):1117–1124. doi: 10.1056/NEJM199704173361601. [DOI] [PubMed] [Google Scholar]
- 18.Appel L.J., Sacks F.M., Carey V.J., et al. Effects of protein, monounsaturated fat and carbohydrate intake on blood pressure and serum lipids. Results of the OmniHeart Randomized trial. JAMA. 2005;294(19):2455–2464. doi: 10.1001/jama.294.19.2455. [DOI] [PubMed] [Google Scholar]
- 19.Lean M.E.J., Leslie W.S., Barnes A.C., et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomized trial. Lancet. 2018;391:541–551. doi: 10.1016/S0140-6736(17)33102-1. [DOI] [PubMed] [Google Scholar]
- 20.Magkos F., Hjarth M.F., Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16:545–555. doi: 10.1038/s41574-020-0381-5. [DOI] [PubMed] [Google Scholar]
- 21.Schwartz M.W., Seeley R.J., Zeltser L.M., et al. Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev. 2017;38:267–296. doi: 10.1210/er.2017-00111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Camacho S., Ruppel A. Is the calorie concept a real solution to the obesity epidemic? Glob Health Action. 2017 doi: 10.1080/16549716.2017.1289650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dansinger M.L., Tatsioni A., Wong W.B., et al. Meta-analysis: the effect of dietary counselling for weight loss. Arch Intern Med. 2007;147:41–50. doi: 10.7326/0003-4819-147-1-200707030-00007. [DOI] [PubMed] [Google Scholar]
- 24.Gary Taubes. Alfred A Knopf; New York: 2011. Why We Get Fat, and what to Do about it. [Google Scholar]
- 25.Leibel R.L., Rosenbaum M., Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621–628. doi: 10.1056/NEJM199503093321001. [DOI] [PubMed] [Google Scholar]
- 26.Gardner C.D., Kiazand A., Alhassan S., et al. Comparison of the atkins, zone, ornish, & learn diets for change in weight and related risk factors among overweight premenopausal women the A to Z weight loss study: a randomized trial. JAMA. 2007;297:969–977. doi: 10.1001/jama.297.9.969. [DOI] [PubMed] [Google Scholar]
- 27.Bhupathiraju S.N., Tobias D.K., Malik V.S., et al. Glycemic index, glycemic load, and risk of type 2 diabetes: results of 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr. 2014;100:218–232. doi: 10.3945/ajcn.113.079533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fan J., Song Y., Hui R., et al. Dietary glycemic index, glycemic load, and risk of CHD, stroke and stroke mortality: a systematic review with meta-analysis. PLoS One. 2012;7 doi: 10.1371/journal.pone.0052182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lennerz B.S., Alsop D.C., Holsen L.M., et al. Effects of dietary glycemic index on brain regions related to reward and craving in men. Am J Clin Nutr. 2013;98:641–647. doi: 10.3945/ajcn.113.064113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Te Morenga L.A., Howatson A.J., Jones R.M., et al. Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clin Nutr. 2014;100:65–79. doi: 10.3945/ajcn.113.081521. [DOI] [PubMed] [Google Scholar]
- 31.Ginsberg H.N., Li-Shin Huang. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk. 2000;7:325–331. doi: 10.1177/204748730000700505. [DOI] [PubMed] [Google Scholar]
- 32.Barter P.J., Brewer B., Jr., Chapman M.J., et al. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:160–167. doi: 10.1161/01.atv.0000054658.91146.64. [DOI] [PubMed] [Google Scholar]
- 33.Menke Andy, Casagrande Sarah, Geiss Linda, Catherine C., Cowie Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021–1029. doi: 10.1001/jama.2015.10029. [DOI] [PubMed] [Google Scholar]
- 34.Bailing M., Afzal S., Varbo A., et al. VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with ApoB-containing lipoproteins. J Am Coll Cardiol. 2020;76:2725–2735. doi: 10.1016/j.jacc.2020.09.610. [DOI] [PubMed] [Google Scholar]
- 35.Food and Nutrition Board, Institute of Medicine . National Academies Press; Washington DC: 2002. Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. [DOI] [PubMed] [Google Scholar]
- 36.Appel L.J., Van Horn L. Did the PREDIMED trial test a Mediterranean diet? N Engl J Med. 2013;368:1353–1354. doi: 10.1056/NEJMe1301582. [DOI] [PubMed] [Google Scholar]
- 37.Mensink R.P., Zock P.L., Kester A.D., et al. Effects of Dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta – analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146–1155. doi: 10.1093/ajcn/77.5.1146. [DOI] [PubMed] [Google Scholar]
- 38.D'Andrea E., Hey S.P., Ramirez C.L., Kesselheim A.S. Assessment of the role of niacin in managing cardiovascular disease outcomes: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(4) doi: 10.1001/jamanetworkopen.2019.2224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mach F., Baigent C., Catapano A.L., et al. For the ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the ESC and EAS. Eur Heart J. 2019;41:111–188. doi: 10.1093/eurheartj/ehz455. [DOI] [PubMed] [Google Scholar]
- 40.Sacks F.M., Lichtenstein A.H., Wu J.H.Y., et al. On behalf of American heart association. Dietary fats and cardiovascular disease: a presidential advisory from the American heart association. Circulation. 2017;136:e1–e23. doi: 10.1161/CIR.0000000000000510. [DOI] [PubMed] [Google Scholar]
- 41.Select Committee on Nutrition and Human Needs . U.S. Government Printing Office; Washington, DC: 1977. (Dietary Goals for the United States). [Google Scholar]
- 42.2015-2020 Dietary Guidelines for americans-health.gov. https://health.gov/dietaryguidelines/2015.
- 43.Enkhman B., Peterson K.S., Kris-Etherton P.M., Berglund L. Diet and Lp(a): does dietary change modify residual cardiovascular risk conferred by Lp(a)? Nutrients. 2020;12:2024. doi: 10.3390/nu12072024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Heileson J.L. Dietary saturated fats and heart disease: a narrative review. Nutr Rev. 2019;78(6):474–485. doi: 10.1093/nutrit/nuz091. [DOI] [PubMed] [Google Scholar]
- 45.Astrup A., Magkos F., Bier D.M., et al. Saturated fats and health: a reassessment and proposal for food-based recommendations. J Am Coll Cardiol. 2020;76:844–857. doi: 10.1016/j.jacc.2020.05.077. [DOI] [PubMed] [Google Scholar]
- 46.Heart and Stroke Foundation of Canada Position Statement: Saturated fat, heart disease and stroke. 2015. Available from: https://www.heartandstroke.ca/-/media/pdf-files/Canada/position-statement/saturatedfat-eng-final.ashx.
- 47.Skeaff C.M., Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomized controlled trials. Ann Nutr Metab. 2009;55:173–201. doi: 10.1159/000229002. [DOI] [PubMed] [Google Scholar]
- 48.Siri-Tarano P.W., Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fats with cardiovascular disease. Am J Clin Nutr. 2010;91:535–546. doi: 10.3945/ajcn.2009.27725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Chowdhury R., Warnakula S., Kunutsor S., et al. A systematic review and meta-analysis. Association of dietary, circulating and supplement fatty acids with coronary risk. Ann Intern Med. 2014;160:398–406. doi: 10.7326/M13-1788. [DOI] [PubMed] [Google Scholar]
- 50.Li Y., Hruby A, Bernstein AM, et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study. J Am Coll Cardiol. 2015;66(14):1538–1548. doi: 10.1016/j.jacc.2015.07.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wang D.D., Li Y, Chiuve SE, et al. Association of specific dietary fats with total and cause-specific mortality. JAMA Intern Med. 2016;176(8):1134–1145. doi: 10.1001/jamainternmed.2016.2417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Jakobsen M.J., O'Reilly E.J., Heitmann B.L., et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425–1432. doi: 10.3945/ajcn.2008.27124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mozaffarian D., Rimm E.B., Herrington D.M. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in post-menopausal women. Am J Clin Nutr. 2004;80:1175–1184. doi: 10.1093/ajcn/80.5.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hooper L., Martin N., Abdelhamid A., et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2015;6 doi: 10.1002/14651858.CD011737. (Review) [DOI] [PubMed] [Google Scholar]
- 55.Shih C.W., Hauser M.E., Aronica L., Rigdon J., Gardner C.D. Changes in blood lipid concentrations associated with changes in intake of dietary saturated fat in the context of a healthy low-carbohydrate weight loss diet: a secondary analysis of the DIETFITS Trial. Am J Clin Nutr. 2019;109:433–441. doi: 10.1093/ajcn/nqy305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Mozaffarian Dariush, Rimm Eric B., Herrington David M. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004;80(5):1175–1184. doi: 10.1093/ajcn/80.5.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.American Diabetes Association Standards of medical care in diabetes-2015. Diabetes Care. 2015;38(Suppl 1):S1–S93. [PubMed] [Google Scholar]
- 58.Johnston B.C., Zeraatkar D., Han M.A., et al. Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the Nutritional Recommendations (NutriRECS) Consortium. Ann Intern Med. 2019;171:756–764. doi: 10.7326/M19-1621. [DOI] [PubMed] [Google Scholar]
- 59.Leren P. The Oslo Diet-Heart study: eleven-year report. Circulation. 1970;42:935–942. doi: 10.1161/01.cir.42.5.935. [DOI] [PubMed] [Google Scholar]
- 60.Ramsden C.E., Zamora D., Majchrzak-Hong S., et al. Re-evaluation of the traditional diet heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73) BMJ. 2016;353:i1246. doi: 10.1136/bmj.i1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ramsden C.E., Zamora D., Leelarthaepin B., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346 doi: 10.1136/bmj.e8707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Li J., Guasch-Ferre M., Li Y., Hu F.B. Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr. 2020;112:150–167. doi: 10.1093/ajcn/nqz349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Bhatt D.L., Steg P.G., Miller M., et al. For the REDUCE-IT Investigators. Cardiovascular risk reduction with eicosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22. doi: 10.1056/NEJMoa1812792. [DOI] [PubMed] [Google Scholar]
- 64.Nicholls S.J., Lincoff A.M., Garcia M., et al. Effect of high dose omega-3 fatty acids vs. corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA. 2020;324(22):2268–2280. doi: 10.1001/jama.2020.22258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Manson J.E., Cook N.R., Lee I.M., et al. VITAL Research Group. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019;380(1):23–32. doi: 10.1056/NEJMoa1811403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Ghafoorunnisa Impact of quality of dietary fat on serum cholesterol and CHD: focus on plant sterols and other non-glyceride components. Natl Med J India. 2009;22:126–132. [PubMed] [Google Scholar]
- 67.Gao D., Ning N., Wang C., et al. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One. 2013;8 doi: 10.1371/journal.pone.0073965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.de Oliveira Otto M.C., Nettleton J.A., Lemaitre R.N., et al. Biomarkers of dairy fatty acids and risk of CVD in the Multi-Ethnic study of Atherosclerosis. J Am Heart Assoc. 2013;2 doi: 10.1161/JAHA.113.000092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Imamura F., Frets A., Marklund M., et al. FORCE. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies. PLoS Med. 2018;15(10) doi: 10.1371/journal.pmed.1002670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Mani I., Kurpad A.V. Fats & fatty acids in Indian diets: time for serious introspection. Indian J Med Res. 2016;144(4):507–514. doi: 10.4103/0971-5916.200904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.US Department of Agriculture and US Department of Health and Human Services . 9th ed. 2020. Dietary Guidelines for Americans; pp. 2020–2025. Available at: DietaryGuideines.gov. [Google Scholar]
- 72.Jones P.J.H, Senanayake VK, Pu S, et al. DHA-enriched high oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola multicenter randomized controlled trial (COMIT) Am J Clin Nutr. 2014;100(1):88–97. doi: 10.3945/ajcn.113.081133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Khaw K.-T., Sharp S.J., Finikarides L., et al. Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women. BMJ Open. 2018;8 doi: 10.1136/bmjopen-2017-020167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Castaner O., Pinto X., Subirana I., et al. Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020;76:2712–2724. doi: 10.1016/j.jacc.2020.10.008. [DOI] [PubMed] [Google Scholar]
- 75.National Institute of Nutrition . 2nd ed. 2011. Dietary Guidelines for Indians—A Manual. [Google Scholar]
- 76.DiNicolantonio J.J., O'Keefe J.H. Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis. Open Heart. 2018;5 doi: 10.1136/openhrt-2018-000898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Freitas H.R., Isaac A.R., Malcher-Lopes R., et al. Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutr Neurosci. 2018;21(10):695–714. doi: 10.1080/1028415X.2017.1347373. [DOI] [PubMed] [Google Scholar]
- 78.Schwingshackl L., Hoffman G. Long term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr J. 2013;12:48. doi: 10.1186/1475-2891-12-48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Seidelmann S.B., Clagget B., Cheng S., et al. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health. 2018;3:e419–e428. doi: 10.1016/S2468-2667(18)30135-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Davis W. Rodale; New York: 2011. Wheat Belly. [Google Scholar]
- 81.Soliman G.A. Dietary cholesterol and the lack of evidence in cardiovascular disease. Nutrients. 2018;10:780. doi: 10.3390/nu10060780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Carson J.A.S., Lichtenstein A.H., Anderson C.A.M., et al. AHA Science Advisory. Dietary cholesterol and cardiovascular risk: a science advisory from the AHA. Circulation. 2020;141:e39–e53. doi: 10.1161/CIR.0000000000000743. [DOI] [PubMed] [Google Scholar]
- 83.Shin J.Y., Xun P., Nakamura Y., He K. Egg consumption in relation to risk of CVD and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98:146–159. doi: 10.3945/ajcn.112.051318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Zhong V.W., Van Horn L., Cornelis M.C., et al. Associations of dietary cholesterol or egg consumption with incident cardiovascular disease and mortality. JAMA. 2019;321:1081–1095. doi: 10.1001/jama.2019.1572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Qin C., Lv J., Bian Z., et al. Associations of egg consumption with cardiovascular disease in a cohort study of 0.5 million Chinese adults. Hear. 2018;104:1756–1763. doi: 10.1136/heartjnl-2017-312651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Dehghan M., Mente A., Rangrajan S., et al. On behalf of the PURE Investigators. Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries. Am J Clin Nutr. 2020;111:795–803. doi: 10.1093/ajcn/nqz348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Mozaffarian D. Dairy foods, dairy fat, diabetes and death: what can be learned from 3 large new investigations? Am J Clin Nutr. 2019;110:1053–1054. doi: 10.1093/ajcn/nqz250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Ding M., Bhupathiraju S.N., Satija A., et al. Long-term coffee consumption and risk of CVD: a systematic review and dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129:643–659. doi: 10.1161/CIRCULATIONAHA.113.005925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Chieng D., Canovas R., Segan L., et al. The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank. Eur J Prev Cardiol. 2022;29(17):2240–2249. doi: 10.1093/eurjpc/zwac189. [DOI] [PubMed] [Google Scholar]
- 90.Zhang C., Qin Y.Y., Wei X., et al. Tea consumption and risk of CV outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. EJE (Eur J Epidemiol) 2015;30:103–113. doi: 10.1007/s10654-014-9960-x. [DOI] [PubMed] [Google Scholar]
- 91.He F.J., Tan M., Ma Y., MacGregor G.A. Salt reduction to prevent hypertension and cardiovascular disease. JACC State-of-the-Art review. J Am Coll Cardiol. 2020;75:632–647. doi: 10.1016/j.jacc.2019.11.055. [DOI] [PubMed] [Google Scholar]
- 92.Aburto N.J., Ziolkovska A., Hooper L., et al. Effect of lower sodium intake on health: systematic review and meta-analysis. Br Med J. 2013;346:fl326. doi: 10.1136/bmj.f1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Graudal N., Jurgens G., Baslund B., Alderman M.H. Compared with usual sodium intake, low and excessive sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens. 2014;27(9):1129–1137. doi: 10.1093/ajh/hpu028. [DOI] [PubMed] [Google Scholar]
- 94.Graudal NA, Hubeck-Graudal T, Jurgens G. effects of low sodium diet versus high sodium diet on BP, renin, aldosterone, catecholamines, cholesterol and triglyceride. Version published: !2 December 2020. 10.1002/14651858.CD004022.pub5. [DOI] [PMC free article] [PubMed]
- 95.Aljuraiban G.S., Jose A.P., Gupta P., et al. Sodium intake, health implications, and the role of population-level strategies. Nutr Rev. 2020 doi: 10.1093/nutrit/nuaa042. [DOI] [PubMed] [Google Scholar]
- 96.Mente A, O'Donnel M, Rangarajan S, et al; for the PURE, EPIDREAM and ONTARGET/TRANSCEND Investigators. Association of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. 10.1016/S0140-6736(16)30510-4. [DOI] [PubMed]
- 97.Welsh C.E., Welsh P., Jhund P., et al. Urinary sodium excretion, blood pressure, and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease. Hypertension. 2019;73:1202–1209. doi: 10.1161/HYPERTENSIONAHA.119.12726. [DOI] [PubMed] [Google Scholar]
- 98.O'Donnell M., Mente A., Alderman M.A., et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. Eur Heart J. 2020;41:3363–3373. doi: 10.1093/eurheartj/ehaa586. [DOI] [PubMed] [Google Scholar]
- 99.Messerli F.H., Hofstetter L., Syrogiannouli L., et al. Sodium intake, life expectancy and all-cause mortality. Eur Heart J. 2021;42:2103–2112. doi: 10.1093/eurheartj/ehaa947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Rosengren A. Salt: the sweet spot? Eur Heart J. 2022;43:2889–2891. doi: 10.1093/eurheartj/ehac336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Powles J., Fahimi S., Micha R., et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3(12) doi: 10.1136/bmjopen-2013-003733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Ezekowitz JA, Colin-Ramirez E, Ross H, et al. reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open label, randomized controlled trial. 10.1016/S0140-6736(22)00369-5. [DOI] [PubMed]
- 103.Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the dietary Approaches to Stop hypertension (DASH) diet. DASH-sodium collaborative research group. N Engl J Med. 2001;344:3–10. doi: 10.1056/NEJM200101043440101. [DOI] [PubMed] [Google Scholar]
- 104.Lasser V.I., Raczynski J.M., Stevens V.J., et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995;5(2):156–164. doi: 10.1016/1047-2797(94)00060-7. [DOI] [PubMed] [Google Scholar]
- 105.Whelton P.K., Appel L.J., Espeland M.A., et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279(11):839–846. doi: 10.1001/jama.279.11.839. [DOI] [PubMed] [Google Scholar]
- 106.Ma H., Xue Q., Wang X., et al. Adding salt to foods and hazard of premature mortality. Eur Heart J. 2022;43:2878–2888. doi: 10.1093/eurheartj/ehac208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Neal Bruce, Wu Yangfeng, Feng Xiangxian, et al. Effects of salt substitution on cardiovascular disease and death. N Engl J Med. 2021;385:1067–1077. doi: 10.1056/NEJMoa2105675. [DOI] [PubMed] [Google Scholar]
- 108.Johnson Claire, Santos Joseph Alvin, Sparks Emalie. Sources of dietary salt in north and south India estimated from 24 hour dietary recall. Nutrients. 2019;11:318. doi: 10.3390/nu11020318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.McLaughlin T., Abbasi F., Lamendola C., et al. Carbohydrate induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations. J Clin Endocr Metab. 2000;85:3085–3088. doi: 10.1210/jcem.85.9.6838. [DOI] [PubMed] [Google Scholar]
- 110.Yang Q., Zhang Z., Gregg E.W., et al. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. 2014;174:516–524. doi: 10.1001/jamainternmed.2013.13563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Singh G.M., Micha R., Khatibzadeh S., et al. Estimated global, regional and national disease burdens related to sugar-sweetened beverage consumption in 2010. Circulation. 2015;132:639–666. doi: 10.1161/CIRCULATIONAHA.114.010636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.World Health Organization . 2015. http://www.who.int/nutrition/publications/guidelines/sugars_intake/en/.March (Sugar Intake for Adults and Children). [Google Scholar]
- 113.Xi B., Huang Y., Reilly K.H., et al. Sugar sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. Br J Nutr. 2015;113:709–717. doi: 10.1017/S0007114514004383. [DOI] [PubMed] [Google Scholar]
- 114.Peres-Pozo S.E., Schold J., Nakagawa T., et al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes. 2010;34:454–461. doi: 10.1038/ijo.2009.259. [DOI] [PubMed] [Google Scholar]
- 115.Gan Y., Tong X., Li L., et al. Consumption of fruit and vegetable and risk of CHD: a meta-analysis of prospective cohort studies. Int J Cardiol. 2015;183:129–137. doi: 10.1016/j.ijcard.2015.01.077. [DOI] [PubMed] [Google Scholar]
- 116.Afshin A., Micha R., Khatibzadeh H., Mozaffarian D. Consumption of nuts and legumes and risk of incident IHD, stroke and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:278–288. doi: 10.3945/ajcn.113.076901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Pan A., Sun Q., Bernstein A.M., et al. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr. 2011;94:1088–1096. doi: 10.3945/ajcn.111.018978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Sinha R., Cross A.J., Graubard B., et al. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169:562–571. doi: 10.1001/archinternmed.2009.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Abete I., Romancera D., Vieira A.R., et al. Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality.: a meta-analysis of cohort studies. Br J Nutr. 2014;112:762–775. doi: 10.1017/S000711451400124X. [DOI] [PubMed] [Google Scholar]
- 120.Grasgruber P., Sebera M., Hrazdira E. Food Consumption and the actual Statistics of cardiovascular disease: an epidemiological comparison of 42 European Countries. Food Nutr Res. 2016;60 doi: 10.3402/fnr.v60.31694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Leroy F., Cofnas N. Should dietary guidelines recommend low meat intake? Crit Rev Food Sci Nutr. 2020;60(16):2763–2772. doi: 10.1080/10408398.2019.1657063. [DOI] [PubMed] [Google Scholar]
